Epinephrine-induced Insulin Resistance in Man
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.
Abstract
Endogenous release of epinephrine after stress as well as exogenous epinephrine infusion are known to result in impaired glucose tolerance. Previous studies of man and animals have demonstrated that this effect of epinephrine results from inhibition of insulin secretion and augmentation of hepatic glucose production. However, the effect of epinephrine on tissue sensitivity to insulin, and the relative contributions of peripheral vs. hepatic resistance to impaired insulin action, have not been defined. Nine young normal-weight subjects were studied with the insulin clamp technique. Plasma insulin was raised by approximately 100 muU/ml while plasma glucose concentration was maintained at basal levels by a variable glucose infusion. Under these conditions of euglycemia, the amount of glucose metabolized equals the glucose infusion rate and is a measure of tissue sensitivity to insulin. Subjects received four studies: (a) insulin (42.6 mU/m(2).min), (b) insulin plus epinephrine (0.05 mug/kg.min), (c) insulin plus epinephrine plus propranolol (1.43 mug/kg.min), and (d) insulin plus propranolol. During insulin administration alone, glucose metabolism averaged 5.49+/-0.58 mg/kg.min. When epinephrine was infused with insulin, glucose metabolism fell by 41% to 3.26 mg/kg.min (P < 0.001). After insulin alone, hepatic glucose production declined by 92% to 0.16+/-0.08 mg/kg.min. Addition of epinephrine was associated with a delayed and incomplete suppression of glucose production (P < 0.01) despite plasma insulin levels >100 muU/ml. When propranolol was administered with epinephrine, total glucose metabolism was restored to control values and hepatic glucose production suppressed normally. Propranolol alone had no effect on insulin-mediated glucose metabolism. These results indicate that epinephrine, acting primarily through a beta-adrenergic receptor, markedly impairs tissue sensitivity to an increase in plasma insulin levels, and that this effect results from both peripheral and hepatic resistance to the action of insulin.
Overview
CoChat Summary
TL;DR
In nine healthy young adults, epinephrine infusion during euglycemic hyperinsulinemia reduced insulin-mediated glucose metabolism by 41% and blunted insulin suppression of hepatic glucose production. Propranolol reversed both effects, indicating that epinephrine-induced insulin resistance is mediated primarily through β-adrenergic receptors and involves peripheral and hepatic tissues.
Key findings
- During insulin clamp alone, total glucose metabolism averaged 5.49±0.58 mg/kg·min; adding epinephrine (0.05 μg/kg·min) reduced it by 41% to 3.26±0.24 mg/kg·min (P < 0.001).
- Insulin alone suppressed endogenous glucose production by 92% to 0.16±0.08 mg/kg·min; epinephrine caused delayed and incomplete suppression (60–120 min: 0.73±0.18 vs. 0.16±0.08 mg/kg·min; P < 0.005), and during the first 20 min hepatic glucose production rose to 2.58±0.32 vs. 0.49±0.16 mg/kg·min.
- Propranolol with epinephrine restored total glucose metabolism to 5.73±0.67 mg/kg·min, not significantly different from control, and blocked epinephrine’s hepatic effect; propranolol alone had no significant effect (5.28±0.42 mg/kg·min).
- Epinephrine also potentiated the insulin-induced decline in all plasma amino acids except alanine by ~15–20% greater than insulin alone; propranolol reversed this effect.
Methods
- Design: euglycemic insulin clamp with [3-3H]glucose in nine healthy volunteers (five females, four males; age 23–30 yr, mean 26±1 yr; 90–112% ideal body weight, mean 99±2%), each serving as their own control, studied postabsorptive after a 12-h overnight fast.
- Four protocols: insulin alone (42.6 mU/m²·min), insulin plus epinephrine (0.05 μg/kg·min), insulin plus epinephrine plus propranolol, and insulin plus propranolol; plasma glucose was maintained at basal levels while plasma insulin was raised to steady-state ~132–135 μU/ml.
- Analysis: under steady-state euglycemia, glucose infusion rate equals tissue sensitivity to insulin; endogenous glucose production was calculated using tritiated glucose; data are mean±SEM with paired Student’s t tests.
Limitations
- Stated: smaller epinephrine doses, as might be expected in mild to moderate stress, were not examined; no α-adrenergic blocker was administered, so a contribution of α-adrenergic receptors to insulin antagonism cannot be excluded.
- Evident from the text: the sample was small (n=9), young, healthy, and normal-weight, and the clamp period was 2 h; propranolol co-infusion raised plasma epinephrine to 1,441±96 vs. 736±23 pg/ml with epinephrine alone, though the authors state this does not alter interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 4 Not checked · 28 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“an in vivo effect of epinephrine on peripheral glucose metabolism independent of changes in plasma insulin levels has not been conclusively documnented.”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Disputedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
The Discussion reports that epinephrine reduced glucose clearance in conscious dogs despite a two- to fourfold rise in plasma insulin, and concludes that the effect was not mediated primarily by suppressed insulin secretion. This is contrary to the claim that an in vivo peripheral effect had not been documented independently of changes in insulin levels, although the paper does not claim to have excluded every contribution from insulin secretion. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several studies have documented that epinephrine inhibits insulin secretion (1–5)”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Partly supportedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
On p. 120, the paper says epinephrine subsequently inhibits insulin release in dogs. It also reports an initial twofold rise in plasma insulin and describes the effect as biphasic, so the unqualified claim omits an important timing qualification. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [3] 3. Altszuler, N., R. Steele, I. Rathgeb, and R. C. DeBodo. 1967. Glucose metabolism and plasma insulin levels during epinephrine infusion in the dog. Am. J. Physiol. 212(3): 677–682. source
- Supportedcites [4] 4. Coore, H. G., and P. J. Randle. 1964. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem. J. 93: 66–78. source
The Results report that adrenaline (epinephrine) abolished the stimulation of insulin release by high glucose in rabbit pancreas pieces incubated in vitro. The Discussion identifies this inhibitory effect as a major finding. The paper also notes that adrenaline had no effect at low glucose; the citing sentence does not claim inhibition under every condition. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [5] 5. Porte, D. 1967. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46: 86–94. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During both clamp studies in which propranolol was infused, the decline in plasma glucagon was similar to the control insulin clamp study (P < 0.05).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After insulin alone, hepatic glucose production declined by 92% to 0.16±0.08 mg/kg·min.”
plainstates a causen = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During insulin administration alone, glucose metabolism averaged 5.49±0.58 mg/kg·min.”
plainn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 35 claims and every source verdict.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased sympathovagal balance also adds to insulin resistance131”
From Interacting epidemics? Sleep curtailment, insulin resistance, and obesity (2012) · cites this paper as [131]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1210/jcem-50-2-294 · retracted 1980-11-01 · notice 10.1210/jcem-51-5-1201 · this paper published 1980-03-01
Citations
Cites
1 retracted
Soman, V., Shamoon, H., Sherwin, R. S., & Ziegler, W. H. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-294 · Cited by 22
RetractedGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRegulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro
Coore, H., & Randle, P. (1964) · Biochemical Journal · doi:10.1042/bj0930066 · Cited by 540
EFFECT OF EPINEPHRINE ON RAT DIAPHRAGM
Walaas, O., & Walaas, E. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56223-2 · Cited by 410
A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398
Exton, J. H., Robison, G. A., Sutherland, E. W., & Park, C. R. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61771-5 · Cited by 320
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296
Self-citationChristensen, N. J. (1974) · Diabetes · doi:10.2337/diab.23.1.1 · Cited by 287
Mechanism of Plasma Catecholamine Increases During Surgical Stress in Man
HALTER, J. B., PFLUG, A. E., & PORTE, D. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-936 · Cited by 279
Control of Gluconeogenesis in Liver
Exton, J. H., & Park, C. R. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93242-4 · Cited by 278
Cited by
Items 101–200 of 556
The Evidence for a Pathophysiologic Significance of the Sympathetic Overactivity in Hypertension
Julius, S. (1996) · Clinical and Experimental Hypertension · doi:10.3109/10641969609088965 · Cited by 95
The Insulin Receptor: Structure and Functio
Zick, Y. (1989) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238909082554 · Cited by 94
Cimarelli, S., Sauer, F., Morel, O., Ohlmann, P., Constantinesco, A., & Impériale, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.04.025 · Cited by 87
Pretty, C. G., Compte, A. J. L., Chase, J. G., Shaw, G. M., Preiser, J., Penning, S., & Desaive, T. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-17 · Cited by 100
“are altered significantly in critical illness due to the stress response [25-27].”
BackgroundLager, I., Lönnroth, P., von Schenck, H., & Smith, U. (1983) · BMJ · doi:10.1136/bmj.287.6406.1661 · Cited by 85
Danielsson, A., Öst, A., Lystedt, E., Kjølhede, P., Gustavsson, J., Nyström, F. H., & Strålfors, P. (2004) · FEBS Journal · doi:10.1111/j.1432-1033.2004.04396.x · Cited by 90
Hyperinsulinemia in glucose-tolerant women with preeclampsia A controlled study
Martinez Abundis, E. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00448-3 · Cited by 82
Reproducibility of the oral glucose tolerance test in pregnant women
Catalano, P. M., Avallone, D. A., Drago, N. M., & Amini, S. B. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90019-f · Cited by 92
Hormonal effects of norepinephrine on acute glucose disposal in humans: A minimal model analysis
Marangou, A. G., Alford, F. P., Ward, G., Liskaser, F., Aitken, P. M., Weber, K. M., Boston, R. C., & Best, J. D. (1988) · Metabolism · doi:10.1016/0026-0495(88)90124-2 · Cited by 83
Rosen, P., Ohly, P., & Gleichmann, H. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715011-00004 · Cited by 82
Berk, M. A., Clutter, W. E., Skor, D., Shah, S. D., Gingerich, R. P., Parvin, C. A., & Cryer, P. E. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111898 · Cited by 82
Regulation of glucose metabolism by sympathochromaffin catecholamines
Clutter, W. E., Rizza, R. A., Gerich, J. E., & Cryer, P. E. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040104 · Cited by 83
Resting heart rate and risk of hypertension: results of the Kailuan cohort study
Wang, A., Liu, X., Guo, X., Dong, Y., Wu, Y., Huang, Z., Xing, A., Luo, Y., Jonas, J. B., & Wu, S. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000230 · Cited by 84
“Journal of Hypertension and third, sympathetic overactivation leads to an increased insulin resistance via adrenergic stimulation resulting in a cascade of cardiovascular risk factors, atherosclerosis and elevated blood pressure [29].”
BackgroundOlea, E., Agapito, M. T., Gallego‐Martin, T., Rocher, A., Gómez-Niño, Á., Obeso, A., González, C., & Yubero, S. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00454.2014 · Cited by 95
“It has been known since the early 1980s (13) that CAs, particularly E, augment liver glucogenogenesis and glycogenolysis leading to hyperglycemia; at the same time, CAs impair sensitivity to insulin in both peripheral and hepatic tissue with the appearance of a picture of insulin resistance [see (55)] as that encounte…”
BackgroundAlperet, D. J., Rebello, S. A., Khoo, E. Y.-H., Tay, Z., Seah, S. S.-Y., Tai, B.-C., Tai, E.-S., Emady-Azar, S., Chou, C. J., Darimont, C., et al. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz306 · Cited by 80
Mesarwi, O. A., Sharma, E. V., Jun, J. C., & Polotsky, V. Y. (2015) · Sleep and Biological Rhythms · doi:10.1111/sbr.12078 · Cited by 80
Falkner, B. (1990) · Hypertension · doi:10.1161/01.hyp.15.6.681 · Cited by 80
Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes
Frontoni, S., Bracaglia, D., & Gigli, F. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.06.010 · Cited by 90
Lager, I., Attvall, S., Eriksson, B. M., Schenk, H., & Smith, U. (1986) · Diabetologia · doi:10.1007/bf00506530 · Cited by 90
“zation seems to be mediated by fl-adrenoceptor stimulation [9].”
BackgroundResultBenthem, L., Keizer, K., Wiegman, C. H., de Boer, S. F., Strubbe, J. H., Steffens, A. B., Kuipers, F., & Scheurink, A. J. W. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.6.e1286 · Cited by 77
“In obesity, increased HPA axis activity and sympathetic activity are associated with insulin resistance (12, 26, 27), raising the possibility that reflex activation of the HPA axis and sympathoadrenal system resulting from excess portal venous supply of longchain fatty acids plays a role in the induction of visceral o…”
BackgroundMorgenstern, M., Wang, J., Beatty, N., Batemarco, T., Sica, A. L., & Greenberg, H. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.002 · Cited by 76
“Catecholamines increase insulin resistance and decrease insulin-mediated glucose uptake in the periphery.(40) Furthermore, activation of the hypothalamic pituitary adrenal axis is known to impair insulin sensitivity and increase mobilization of glucose.”
BackgroundSleep‐Disordered Breathing and Obesity: Pathophysiology, Complications, and Treatment
Leinum, C. J., Dopp, J. M., & Morgan, B. J. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533609351532 · Cited by 76
Control of Glycolysis and Glycogen Metabolism
Connett, R. J., & Sahlin, K. (1996) · Comprehensive Physiology · doi:10.1002/cphy.cp120119 · Cited by 75
Associations between heart rate and other risk factors in a large French population
Morcet, J.-F., Safar, M., Thomas, F., Guize, L., & Benetos, A. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917120-00003 · Cited by 74
Hormonal control of glucose homoeostasis in ruminants
McDowell, G. (1983) · Proceedings of The Nutrition Society · doi:10.1079/pns19830021 · Cited by 102
Aune, D., ó Hartaigh, B., & Vatten, L. J. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.02.008 · Cited by 73
“Further, epinephrine causes hyperglycaemia by reducing the insulin-mediated glu cose uptake in skeletal muscle cells, while β-adrenergic receptor blockade seems to abolish this effect (30).”
BackgroundPostoperative insulin resistance and circulating concentrations of stress hormones and cytokines
Thorell, A., Loftenius, A., Andersson, B., & Ljungqvist, O. (1996) · Clinical Nutrition · doi:10.1016/s0261-5614(96)80023-9 · Cited by 340
Insulin-counteracting hormones: Their impact on glucose metabolism
Bratusch-Marrain, P. R. (1983) · Diabetologia · doi:10.1007/bf00297384 · Cited by 82
Doehner, W., Rauchhaus, M., Godsland, I. F., Egerer, K., Niebauer, J., Sharma, R., Cicoira, M., Florea, V. G., Coats, A. J. S., & Anker, S. D. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00022-0 · Cited by 78
Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism
Lang, C. H. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.4.e703 · Cited by 74
Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X").
Stern, M. P., Morales, P. A., Haffner, S. M., & Valdez, R. A. (1992) · Hypertension · doi:10.1161/01.hyp.20.6.802 · Cited by 73
“For example, it has been shown that an infusion of epinephrine can produce acute insulin resistance.(57) Thus, it is possible to imagine that a primary disturbance in adrenergic function could produce both insulin resistance and a hyperdynamic circulation.”
BackgroundHulman, S., Falkner, B. E., & Freyvogel, N. (1993) · Metabolism · doi:10.1016/0026-0495(93)90165-k · Cited by 72
Insulin sensitivity, sympathetic activity, and cardiovascular reactivity in young men
Moan, A., Nordby, G., Rostrup, M., EIDE, I., & Kjeldsen, S. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00206-q · Cited by 74
The stressful condition as a nutritionally dependent adaptive dichotomy
Ingenbleek, Y., & Bernstein, L. H. (1999) · Nutrition · doi:10.1016/s0899-9007(99)00009-x · Cited by 80
Hazards in subgroups of human obesity
Björntorp, P. A. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb01174.x · Cited by 73
Mullins, G. R., Wang, L., Raje, V., Sherwood, S. G., Grande, R. C., Boroda, S., Eaton, J. M., Blancquaert, S., Roger, P. P., Leitinger, N., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410530111 · Cited by 80
“Am J Physiol Endocrinol Metab 295(1):E29–E37.”
A gut–brain neural circuit controlled by intestinal gluconeogenesis is crucial in metabolic health
Soty, M., Penhoat, A., Amigo-Correig, M., Vinera, J., Sardella, A., Vullin-Bouilloux, F., Zitoun, C., Houberdon, I., & Mithieux, G. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.12.009 · Cited by 69
“Moreover, epinephrine infusion has long been known to induce hyperglycemia in humans and animals [6] and to cause defects in GSIS [2].”
BackgroundMravec, B., Tibenský, M., Horváthová, Ľ., & Babál, P. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0346 · Cited by 89
“Moreover, metabolic changes induced by an activated sympathoadrenal nervous system (77) might also affect cancer nourishment.”
BackgroundJun, J. C., Shin, M.-K., Devera, R., Yao, Q., Mesarwi, O., Bevans-Fonti, S., & Polotsky, V. Y. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00373.2014 · Cited by 67
Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging
Ghosh, P., Shu, Z.-J., Zhu, B., Lu, Z., Ikeno, Y., Barnes, J. L., Yeh, C., Zhang, B.-X., Katz, M. S., & Kamat, A. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0406 · Cited by 74
Sympathetic overactivity in hypertension: A risk factor for cardiovascular disease
Palatini, P. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0065-z · Cited by 79
“Infusion of epinephrine in human volunteers has been shown to produce acute insulin resistance, which can be blocked with propranolol [ 25 ].”
BackgroundThe physiological basis of insulin treatment ? clinical aspects
Waldh�usl, W. K. (1986) · Diabetologia · doi:10.1007/bf00870138 · Cited by 69
Animal models of insulin resistance and heart failure
Velez, M., Kohli, S., & Sabbah, H. N. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9387-6 · Cited by 73
Hypoglycemia after resection of pheochromocytoma
Chen, Y., Hodin, R. A., Pandolfi, C., Ruan, D. T., & McKenzie, T. J. (2014) · Surgery · doi:10.1016/j.surg.2014.08.020 · Cited by 70
Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle
Raz, I., Katz, A., & Spencer, M. K. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.3.e430 · Cited by 65
Elevated Heart Rate in Cardiovascular Diseases: A Target for Treatment?
Palatini, P. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.05.005 · Cited by 71
β-BLOCKERS IN SEPSIS: REEXAMINING THE EVIDENCE
Novotny, N. M., Lahm, T., Markel, T. A., Crisostomo, P. R., Wang, M., Wang, Y., Ray, R., Tan, J., Al-Azzawi, D., & Meldrum, D. R. (2009) · Shock · doi:10.1097/shk.0b013e318180ffb6 · Cited by 65
“Epinephrine and specific "-adrenergic agonists have been shown to decrease insulin-mediated glucose uptake (38, 39).”
BackgroundCatecholamine-induced insulin resistance of glucose transport in isolated rat adipocytes
Kirsch, D., Baumgarten, M., Deufel, T., Rinninger, F., KEMMLER, W. K., & Häring, H.-U. (1983) · Biochemical Journal · doi:10.1042/bj2160737 · Cited by 64
Acute Effects of Ghrelin on Insulin Secretion and Glucose Disposal Rate in Gastrectomized Patients
Damjanovic, S. S., Lalic, N. M., Pesko, P. M., Petakov, M. S., Jotic, A., Miljic, D., Lalic, K. S., Lukic, L., Djurovic, M., & Djukic, V. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1482 · Cited by 63
The Role of the Autonomic Nervous System in Hypertension.
Amerena, J., & Julius, S. (1995) · Hypertension Research · doi:10.1291/hypres.18.99 · Cited by 63
Hoelzer, D. R., Dalsky, G. P., Clutter, W. E., Shah, S. D., Holloszy, J. O., & Cryer, P. E. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112279 · Cited by 62
RetractedAdrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
Simonson, D. C., Koivisto, V, Sherwin, R. S., Ferrannini, E., Hendler, R., Juhlin-Dannfelt, A., & DeFronzo, R. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111371 · Cited by 63
Self-citationEffects of morphine on glucose homeostasis in the conscious dog.
Radosevich, P. M., Williams, P. E., Lacy, D. B., McRae, J. R., Steiner, K., Cherrington, A. D., LACY, W. W., & Abumrad, N. N. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111560 · Cited by 64
Insulin resistance and blood pressure regulation in obese and nonobese subjects. Special lecture.
Rocchini, A. P. (1991) · Hypertension · doi:10.1161/01.hyp.17.6.837 · Cited by 62
Association between Glucose Metabolism and Sleep-disordered Breathing during REM Sleep
Chami, H. A., Gottlieb, D. J., Redline, S., & Punjabi, N. M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0046oc · Cited by 60
“Multiple mechanisms could mediate the association of AHIREM and impaired glucose metabolism including intermittent hypoxemia (40, 41), recurrent arousal/sleep fragmentation (42, 43), sympathetic stimulation (44, 45), alteration in corticotropic regulation (46, 47), and potentially other effects of selective REMsleep d…”
BackgroundDietary Sodium Restriction Impairs Insulin Sensitivity in Noninsulin-Dependent Diabetes Mellitus1
Petrie, J. R., Morris, A. D., Minamisawa, K., Hilditch, T. E., Elliott, H. L., Small, M., & MC Connell, J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4835 · Cited by 59
Yamada, F., Inoue, S., Saitoh, T., Tanaka, K., Satoh, S., & Takamura, Y. (1993) · Endocrinology · doi:10.1210/endo.132.5.8477665 · Cited by 63
Challiss, R. A. J., Lozeman, F. J., Leighton, B., & Newsholme, E. A. (1986) · Biochemical Journal · doi:10.1042/bj2330377 · Cited by 61
Increased insulin sensitivity and responsiveness during lactation in rats
Burnol, A., Leturque, A., Ferré, P., Kandé, J., & Girard, J. R. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.5.e537 · Cited by 60
Mechanisms of Epinephrine-induced Glucose Intolerance in Normal Humans
Saccà, L., Vigorito, C., Cicala, M., Ungaro, B., & Sherwin, R. S. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110451 · Cited by 59
Glucoregulation during and after intense exercise: effects of beta-blockade.
Sigal, R. J., Purdon, C., Bilinski, D., Vranic, M., Halter, J. B., & Marliss, E. B. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.7906280 · Cited by 59
Adipocyte lipolysis drives acute stress-induced insulin resistance
Raje, V., Ahern, K. W., Martínez, B. A., Howell, N. L., Oenarto, V., Granade, M. E., Kim, J. W., Tundup, S., Bottermann, K., Gödecke, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75321-0 · Cited by 65
Knudsen, S. H., Karstoft, K., Pedersen, B. K., van Hall, G., & Solomon, T. P. J. (2014) · Physiological Reports · doi:10.14814/phy2.12114 · Cited by 64
Clinical Pharmacology of Sulphonylurea Hypoglycaemic Agents: Part 2
Jackson, J. E., & BRESSLER, R. C. (1981) · Drugs · doi:10.2165/00003495-198122040-00003 · Cited by 62
Relationship Between Intermittent Hypoxia and Type 2 Diabetes in Sleep Apnea Syndrome
Ota, H., Fujita, Y., Yamauchi, M., Muro, S., Kimura, H., & Takasawa, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194756 · Cited by 60
“As catecholamines are widely known to reduce peripheral insulin-sensitive glucose uptake and to increase insulin resistance [86], these findings strongly suggest that IH causes insulin resistance in peripheral organs/tissues via the increased release of catecholamines from sympathetic neural system.”
BackgroundLaakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.2.e199 · Cited by 57
Palatini, P. (1999) · Drugs · doi:10.2165/00003495-199957050-00004 · Cited by 64
“In fact, it has been shown that sympathetic overactivity may cause insulin resistance through acute stimulation of β-adrenoceptors in human volunteers, an effect which can be blocked by propranolol.[32]”
BackgroundMetabolic syndrome and breast cancer risk
Wani, B., Aziz, S. A., Ganaie, M. A., & Mir, M. H. (2017) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/ijmpo.ijmpo_168_16 · Cited by 60
“[54] Apart from decrease in insulin sensitivity or insulin secretion, which cause increased glucose production and decreased glucose utilization, [55] gluconeogenesis is stimulated by counterregulatory hormones such as adrenal hormones, androgens, and GHs. [56,57] These hormones are determinants of fasting glucose, an…”
BackgroundHyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Ayala, J. E., Bracy, D. P., Malabanan, C., James, F. D., Ansari, T., Fueger, P. T., McGuinness, O. P., & Wasserman, D. H. (2011) · Journal of Visualized Experiments · doi:10.3791/3188-v · Cited by 56
The effect of dietary salt on insulin sensitivity
FLISER, D., FODE, P., ARNOLD, U., NOWICKI, M., KOHL, B., & RITZ, E. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01523.x · Cited by 55
Fogari, R., Zoppi, A., Corradi, L., Preti, P. S., Malalamani, G. D., & Mugellini, A. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018120-00023 · Cited by 57
Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men
Townsend, R. R., & DiPette, D. J. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.3.e362 · Cited by 64
Cardiovascular and metabolic responses to submaximal exercise in hemodialysis patients
Kettner, A., Goldberg, A., Hagberg, J. M., Delmez, J. A., & Harter, H. R. (1984) · Kidney International · doi:10.1038/ki.1984.135 · Cited by 59
Higher Heart Rate Predicts the Risk of Developing Hypertension in a Normotensive Screened Cohort
Inoue, T., Iseki, K., Iseki, C., Kinjo, K., Ohya, Y., & Takishita, S. (2007) · Circulation Journal · doi:10.1253/circj.71.1755 · Cited by 58
Consequences of the Increased Autonomic Nervous Drive in Hypertension, Heart Failure and Diabetes
Julius, M. (1998) · Blood Pressure · doi:10.1080/080370598438410-1 · Cited by 63
Hypertension and Insulin Resistance Are Not Directly Related in Obese Dogs
Rocchini, A. P., Yang, J. Q., & Gokee, A. (2004) · Hypertension · doi:10.1161/01.hyp.0000123073.48855.e9 · Cited by 52
Dynamic peripheral nerve metabolic and vascular responses to exsanguination
Takeuchi, M., & Low, P. A. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.253.4.e349 · Cited by 53
Jamerson, K., Smith, S., Amerena, J. V., Grant, E. J., & Julius, S. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1006 · Cited by 56
Insulin action during fasting and refeeding in rat determined by euglycemic clamp
Penicaud, L., Kande, J., Le Magnen, J., & Girard, J. R. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.249.5.e514 · Cited by 50
Heart rate as a cardiovascular risk factor: do women differ from men?
Palatini, P. (2001) · Annals of Medicine · doi:10.3109/07853890108998748 · Cited by 52
Modulation of the action of insulin by angiotensin-(1–7)
Dominici, F. P., Burghi, V., Muñoz, M. C., & Giani, J. F. (2014) · Clinical Science · doi:10.1042/cs20130333 · Cited by 52
Chu, C. A., Sindelar, D. K., Igawa, K., Sherck, S. M., Neal, D. W., Emshwiller, M., & Cherrington, A. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.2.e463 · Cited by 53
“In agreement with our data, Deibert and DeFronzo (9) reported that, in the presence of a euglycemic-hyperinsulinemic clamp, all of the effects of epinephrine on glucose production in the human could be accounted for by a b-adrenergic mechanism.”
ResultMacko, A. R., Yates, D. T., Chen, X., Green, A. S., Kelly, A. C., Brown, L. D., & Limesand, S. W. (2013) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174413000093 · Cited by 58
“the role that NE plays in enhanced insulin sensitivity, which may include actions that are independent of suppressed insulin secretion.(25,42,50) During the basal period, adrenergic blockade reduced glucose concentrations in PI fetuses without increasing insulin concentrations, which indicates greater glucose utilizat…”
BackgroundIn Vivo Regulation of Non-Insulin-Mediated and Insulin-Mediated Glucose Uptake by Epinephrine*
BARON, A. D., WALLACE, P., & OLEFSKY, J. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-889 · Cited by 50
Qvisth, V., Toft, E., Enoksson, S., & Bolinder, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1313 · Cited by 59
Obstructive Sleep Apnea and the Liver
Parikh, M. P., Gupta, N. M., & McCullough, A. J. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.01.001 · Cited by 57
Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study
Valensi, P. E., Extramiana, F., Lange, C., Cailleau, M., Haggui, A., Maison‐Blanche, P., Tichet, J., Balkau, B., & for the DESIR Study Group (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03222.x · Cited by 54
“Higher sympathetic tone can cause insulin resistance [20].”
BackgroundGlucoregulation during and after intense exercise: Effects of α-adrenergic blockade
Sigal, R. J., Fisher, S. J., Manzon, A., Morais, J. A., Halter, J. B., Vranić, M., & Marliss, E. B. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90374-3 · Cited by 56
Laurent, D., Petersen, K. F., Russell, R. R., Cline, G. W., & Shulman, G. I. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.1.e130 · Cited by 48
“Finally, it is well known that an increase in plasma epinephrine concentration causes insulin resistance (13, 37), although the mechanism for this effect remains unclear.”
BackgroundBoscaro, M., Giacchetti, G., & Ronconi, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06597.x · Cited by 56
Exercise Intensity Modulation of Hepatic Lipid Metabolism
Lira, F. S., Carnevali, L. C., Zanchi, N. E., dos Santos, R. V. T., Lavoie, J.-M., & Seelaender, M. C. L. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/809576 · Cited by 54
“Secondly, circulating glucose levels often increases at high-intensity training and this may prevent the fall or even lead to a increase in insulin levels [54], suppressing glucagon effects, but not affecting catecholamine’s function considerably [55, 56].”
BackgroundType 2 Diabetes Mellitus and the Catabolic Response to Surgery
Schricker, T., Gougeon, R., Eberhart, L. H. J., Wykes, L., Mazza, L., Carvalho, G., & Carli, F. (2005) · Anesthesiology · doi:10.1097/00000542-200502000-00013 · Cited by 47
“All these hormones inhibit insulin secretion and/or counteract the peripheral action of insulin, leading to a state of impaired tissue insulin sensitivity.(2,3) Insulin resistance is thought to be one of the principal mechanisms responsible for the catabolic responses to surgery, including stimulated amino acid oxidat…”
BackgroundSavontaus, E., Fagerholm, V., Rahkonen, O., & Scheinin, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.09.015 · Cited by 47
β-Adrenergic dependent downregulation of insulin binding in rat adipocytes
Lönnroth, P., & Smith, U. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91713-8 · Cited by 45
Nutrition Support Strategies for Severely Burned Patients
Lee, J. O., Benjamin, D., & Herndon, D. N. (2005) · Nutrition in Clinical Practice · doi:10.1177/0115426505020003325 · Cited by 45
Sleep-related intermittent hypoxemia and glucose intolerance: a community-based study
Tanno, S., Tanigawa, T., Saito, I., Nishida, W., Maruyama, K., Eguchi, E., Sakurai, S., Osawa, H., & Punjabi, N. M. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.05.027 · Cited by 46
“Increase in circulating catecholamines impairs insulin sensitivity [25], decreases insulin secretion [26], and reduces insulin-mediated glucose uptake [27].”
BackgroundTenenbaum, A., & Fisman, E. Z. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404050-00001 · Cited by 50
Effect of cyclic AMP-dependent protein kinase on insulin receptor tyrosine kinase activity
Tanti, J., Grémeaux, T., Rochet, N., et al. (1987) · Biochemical Journal · doi:10.1042/bj2450019 · Cited by 45
Sepsis as a Pan-Endocrine Illness—Endocrine Disorders in Septic Patients
Wasyluk, W., Wasyluk, M., & Zwolak, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102075 · Cited by 51
“Adrenaline and β-adrenergic stimulation has been shown to inhibit insulin-dependent glucose uptake in skeletal muscle [134].”
BackgroundThe effect of caffeine on glucose kinetics in humans - influence of adrenaline
Battram, D. S., Graham, T. E., Richter, E. A., & Dela, F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.097444 · Cited by 44
“Adrenaline in high concentrations (3–4 nm) is known to inhibit insulin-mediated, whole-body glucose disposal by 40–50% (Deibert & DeFronzo, 1980; Bessey et al. 1983; Baron et al. 1987; Laurent et al. 1998).”
Background
Metadata
- Authors
- Deibert, D. C., & Defronzo, R. A.
- Affiliations
- Yale University (US)
- ORCID
- Defronzo, Ralph A.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-03-01
- Volume
- 65
- Issue
- 3
- Pages
- 717-721
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371414
- OpenAlex
- W2064971980
- Cited by
- 557
- References
- 21
- Citations by year
- 2026: 12 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 21 · 2013: 10 · 2012: 18
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- epinephrine, insulin resistance, beta-adrenergic receptors, propranolol, hepatic glucose production, glucose metabolism, insulin secretion, hyperinsulinemic-euglycemic clamp, peripheral insulin sensitivity, stress hyperglycemia
- MeSH terms
- Adult, Amino Acids, Blood Glucose, Drug Resistance, Epinephrine, Female, Glucagon, Glucose, Humans, Insulin, Liver, Male, Propranolol, Receptors, Adrenergic, beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.